Rifampicin increases the clearance and decreases the bioavailability of
tacrolimus. In some cases a 10-fold increase in the
tacrolimus dose has been needed to manage this interaction.
Tacrolimus levels and effects (e.g. on
renal function) should be monitored as a matter of routine, but it is advisable to increase monitoring if
rifampicin is started or stopped.